Alzheimer's disease and dementia

Disease

1 paper3 findings

  • In silico1

Associations

3

Body mass index

upin humans1

1 study
  1. Body mass index raises the risk of Alzheimer's disease and dementia in humans.

    “high‐SDI countries bearing the greatest burden due to modifiable risk factors like fasting plasma glucose and BMI”

    Humansin high-SDI countries

    Global Burden of Alzheimer's Disease and Dementia: Trends in Mortality, Risk Factors and Incidence Across Sustainable Development Index Regions from 1990 to 2021

    AAIC 2025 abstract23 Dec 2025

More on Body mass index

Fasting plasma glucose

upin humans1

1 study
  1. Fasting plasma glucose raises the risk of Alzheimer's disease and dementia in humans.

    “high‐SDI countries experiencing the highest burden, driven primarily by elevated fasting plasma glucose and BMI”

    Humansin high-SDI countries

    Global Burden of Alzheimer's Disease and Dementia: Trends in Mortality, Risk Factors and Incidence Across Sustainable Development Index Regions from 1990 to 2021

    AAIC 2025 abstract23 Dec 2025

More on Fasting plasma glucose

Mortality

no changein humans1

1 study
  1. Alzheimer's disease and dementia is associated with mortality in humans (AAPC 0.004%, 95% CI: -0.0072 to 0.0178).

    “Globally, the age‐standardized death rate (ASDR) for Alzheimer's disease and other dementias remained constant from 1990 to 2021 (AAPC: 0.004%; 95% CI: ‐0.0072 to 0.0178)”

    Humans

    Global Burden of Alzheimer's Disease and Dementia: Trends in Mortality, Risk Factors and Incidence Across Sustainable Development Index Regions from 1990 to 2021

    AAIC 2025 abstract23 Dec 2025

Latest

Nov 2025: 0Dec 2025: 31Jan 2026: 5Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 1Jul 2026: 0Aug 2026: 6Sep 2026: 7Oct 2026: 152 in 12 months
Epidemiology

Ultrafine particle exposure linked to dementia mortality

Each 10,000 particles/cm³ increase in outdoor ultrafine particle concentrations was associated with higher dementia mortality (hazard ratio 1.22, 95% CI 1.17–1.27).Each 10,000 particles/cm³ increase in outdoor ultrafine particle concentrations was associated with higher dementia mortality (hazard ratio 1.22, 95% CI 1.17–1.27).

Cohort study in peopleVascular dementia
Journal of Alzheimer's Disease Reports

Statins cut Alzheimer's risk but raise other dementia risks

A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.

Mendelian randomisation in peopleStatins
Diabetes & Vascular Disease Research

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

Older adults taking GLP-1 agonists showed higher risks of Alzheimer's disease (RR 1.33) and all-cause mortality (RR 1.11) than those on SGLT2 inhibitors.Older adults taking GLP-1 agonists showed higher risks of Alzheimer's disease (RR 1.33) and all-cause mortality (RR 1.11) than those on SGLT2 inhibitors.

Cohort study of 56,211 peopleSGLT2 inhibitors
Journal of Alzheimer's Disease

Tooth loss is tied to faster progression to dementia and death

In 22,205 older adults followed for 12.3 years, complete tooth loss increased the transition risk from mild cognitive impairment to dementia with a hazard ratio of 1.26.In 22,205 older adults followed for 12.3 years, complete tooth loss increased the transition risk from mild cognitive impairment to dementia with a hazard ratio of 1.26.

Cohort study of 22,205 peopleDementia